Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality7/10

Trulieve Q3 2026: healthy margins, DEA milestone, and growth runway

Nov 5, 2026, 6:31 AM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Strong Q3 cash flow and positive GAAP earnings, plus meaningful catalysts (DEA scheduling, NYSE uplist) could drive multiple expansion and attract funds; near-term volatility may persist around regulatory updates and Harvest deconsolidation effects.

AI summary

What happened, with direct paths to the underlying reporting

Trulieve reported Q3 2026 revenue of $230 million with a 64% gross margin and a small GAAP profit, backed by solid cash generation. The key catalyst is the DEA registrations and Schedule III rescheduling, which could unlock tax benefits and broaden capital access as expansion opportunities in Georgia and Texas unfold. The company also completed domestication to Delaware and joined major indices, potentially widening investor access.

Q3 revenue $230.2M; gross margin 64%.
Net income $0.8M; adjusted net income $18M; adjusted EBITDA $89.2M.
Cash from operations $74M; free cash flow $45M; cash $326.7M.
DEA registrations and Schedule III rescheduling milestone achieved.
Delaware domestication completed; NYSE uplisting and index additions.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.